Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Al Bustan, Suzanne A ^a   Al Serri, Ahmad E ^a   Annice, Babitha G ^a   Alnaqeeb, Majed A ^a   Ebrahim, Ghada A ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

APOAI; Arabs; Kuwait; LDL; Polymorphism; Re sequencing; SNPs

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; DNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NUCLEOTIDE;

5' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 11; COHORT ANALYSIS; DIET RESTRICTION; DNA EXTRACTION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; KUWAIT; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGE FACTORS; AGED; ALLELES; APOLIPOPROTEIN A-I; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHOLESTEROL; CHROMOSOMES, HUMAN, PAIR 11; COHORT STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; KUWAIT; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SEX FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84883698565     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-90     Document Type: Article

References (52)

1. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001, 60(3):329-339. 10.1079/PNS200194, 11681807.
2. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N Eng J Med 1993, 328(16):1150-1156.
3. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol 2009, 44(3):136-160. 10.1016/j.exger.2008.11.003, 2730542, 19041386.
4. Andreotti G, Menashe I, Chen J, Chang SC, Rashid A, Gao YT, Han TQ, Sakoda LC, Chanock S, Rosenberg PS, Hsing AW. Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China. Eur J Epidemiol 2009, 24(12):763-774. 10.1007/s10654-009-9402-3, 2885778, 19888660.
5. Goode EL, Cherny SS, Christian JC, Jarvik GP, de Andrade M. Heritability of longitudinal measures of body mass index and lipid and lipoprotein levels in aging twins. Twin Res Hum Genet 2007, 10(5):703-711. 10.1375/twin.10.5.703, 17903110.
6. Breslow JL. Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility. Annu Rev Genet 2000, 34:233-254. 10.1146/annurev.genet.34.1.233, 11092828.
7. Horton JD, Cohen JC, Hobbs HH. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 2007, 32(2):71-77. 10.1016/j.tibs.2006.12.008, 2711871, 17215125.
8. Chasman DI, Paré G, Zee RY, Parker AN, Cook NR, Buring JE, Kwiatkowski DJ, Rose LM, Smith JD, Williams PT, Rieder MJ, Rotter JI, Nickerson DA, Krauss RM, Miletich JP, Ridker PM. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet 2008, 1(1):21-30. 10.1161/CIRCGENETICS.108.773168, 2630707, 19802338.
9. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, Pramstaller PP, Penninx BW, Janssens AC, Wilson JF, Spector T, Martin NG, Pedersen NL, Kyvik KO, Kaprio J, Hofman A, Freimer NB, Jarvelin MR, Gyllensten U, Campbell H, Rudan I, Johansson A, Marroni F, Hayward C, Vitart V, Jonasson I, Pattaro C, Wright A, Hastie N, Pichler I, Hicks AA, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009, 41(1):47-55. 10.1038/ng.269, 2687074, 19060911.
10. Miljkovic I, Yerges-Armstrong LM, Kuller LH, Kuipers AL, Wang X, Kammerer CM, Nestlerode CS, Bunker CH, Patrick AL, Wheeler VW, Evans RW, Zmuda JM. Association analysis of 33 lipoprotein candidate genes in multi-generational families of African ancestry. J Lipid Res 2010, 51(7):1823-1831. 10.1194/jlr.M003897, 2882746, 20308432.
11. Yin RX, Li YY, Liu WY, Lai CQ. Apolipoprotein Al/C3/A5 haplotypes and serum lipid levels. Lipids Health Dis 2011, 10:140. 10.1186/1476-511X-10-140, 3170230, 21854571.
12. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-228.
13. Matsunaga A, Sasaki J, Han H, Huang W, Kugi M, Koga T, Ichiki S, Shinkawa T, Arakawa K. Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency. Arterioscler Thromb Vasc Biol 1999, 19(2):348-355. 10.1161/01.ATV.19.2.348, 9974418.
14. Herron KL, Lofgren IE, Adiconis X, Ordovas JM, Fernandez ML. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis 2006, 184(1):113-20. 10.1016/j.atherosclerosis.2005.03.023, 16326171.
15. Angotti E, Mele E, Costanzo F, Awedimento EV. A polymorphism (G- > A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 1994, 269(26):17371-17374.
16. Wang XL, Badenhop R, Humphrey KE, Wilcken DE. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genetic Epidemiology 1996, 13(1):1-10. 10.1002/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D, 8647374.
17. Kamboh MI, Bunker CH, Aston CE, Nesterlode CS, McAllister AE, Ukoli FA. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol 1999, 16:205-222. 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.0.CO;2-P, 10030402.
18. Ma YQ, Thomas GN, Tomlinson B. Association of two apolipoprotein A-I gene MspI Polymorphisms with lipid and blood pressure levels. Int J Cardiol 2005, 102:309-314. 10.1016/j.ijcard.2004.10.017, 15982502.
19. Haase CL, Tybjærg-Hansen A, Grande P, Frikke-Schmidt R. Genetically elevated Apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease. J Clin Endocrinol Metab 2010, 95(12):E500-E510. 10.1210/jc.2010-0450, 20826588.
20. Li Y, Yin R, Zhou Y, Deng Y, Yang D, Pan S, Lin W. Associations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. Int J Mol Med 2008, 21(6):753-764.
21. Toptas B, Görmüş U, Ergen A, Gürkan H, Keleşoglu F, Darendeliler F, Bas F, Dalan AB, Izbirak G, Isbir T. Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia. In Vivo 2011, 25(3):425-430.
22. Tuteja R, Tuteja N, Melo C, Casari G, Baralle FE. Transription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Lett 1992, 304:98-101. 10.1016/0014-5793(92)80597-A, 1618307.
23. Danek GM, Valenti M, Baralle FE, Romano M. The A/G polymorphism in the -78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency. Biochim Biophys Acta 1998, 1398:67-74. 10.1016/S0167-4781(98)00029-3, 9602064.
24. Talmud PJ, Ye S, Humphries SE. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European atherosclerosis research study. Genet Epidemiol 1994, 11(3):265-280. 10.1002/gepi.1370110305, 8088507.
25. Moriyama K, Sasaki J, Takada Y, Matsunaga A, Fukui J, Albers JJ, Arakawa K. A cysteine containing truncated apolipoprotein A-I associated with high density lipoprotein deficiency. Arterioscler Thromb Vasc Biol 1996, 16:1416-1423. 10.1161/01.ATV.16.12.1416, 8977444.
26. Miccoli R, Bertolotto A, Navalesi R, Odoguardi L, Boni A, Wessling J, Funke H, Wiebusch H, Eckardstein A, Assmann G. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease. Circulation 1996, 94(7):1622-1628. 10.1161/01.CIR.94.7.1622, 8840853.
27. Shioji K, Mannami T, Kokubo Y, Goto Y, Nonogi H, Iwai N. An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese. J Hum Genet 2004, 49(8):433-439.
28. Heng CK, Low PS, Saha N. Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr Res 2001, 49(4):514-518. 10.1203/00006450-200104000-00013, 11264435.
29. Daneshpour MS, Faam B, Mansournia MA, Hedayati M, Mesbah-Namin SA, Shojaei S, Zarkesh M, Azizi F. Haplotype analysis of ApoAI-CIII-AIV gene cluster and lipids level: tehran lipid and glucose study. Endocrine 2012, 41(1):103-110. 10.1007/s12020-011-9526-6, 22105741.
30. Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinda-Thie G, Krauss RM, Sinsheimer JS, Cantor RM, de Bruin TW, Lusis AJ. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res 2004, 94:993-999. 10.1161/01.RES.0000124922.61830.F0, 15001527.
31. Minnich A, DeLangavant G, Lavigne J, Roederer G, Lussier-Cacan S, Davignon J. G- > A substitution at position -75 of the apolipoprotein A-I gene promoter. Evidence against a direct effect on HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1995, 15(10):1740-1745. 10.1161/01.ATV.15.10.1740, 7583551.
32. De Franca E, Alves JG, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res 2005, 38(4):535-541.
33. Hamon SC, Kardia SLR, Boerwinkle E, Liu K, Klos KL, Clark AG, Sing CF. Evidence for consistent intragenic and intergenic interactions between SNP effects in the APOA1/C3/A4/A5 Gene cluster. Hum Hered 2006, 61(2):87-96. 10.1159/000093384, 1698960, 16710093.
34. Johansen K, Dunn B, Tan JC, Kwassi AA, Skotnicki A, Skotnicki M. Coronary artery disease and apolipoprotein AI-CIII gene polymorphism: a study of Saudi Arabians. Clin Genet 1991, 39(1):1-5.
35. Al-Yahyaee SA, Al-Kindi MN, Al-Bahrani AI. Apolipoprotein A1 gene polymorphisms at the -75 bp and +83/ 84 bp polymorphic sites in healthy Omanis compared with world populations. Hum Biol 2004, 76(2):307-312. 10.1353/hub.2004.0028, 15359539.
36. Olusi SO, Al-Awadi AM, Abraham M. Baseline population survey data on the prevalence of risk factors for coronary artery disease among Kuwaitis aged 15 years and older. Ann Saudi Med 2003, 23(3-4):162-166.
37. Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology 2010, 61(1):42-48. 10.1177/0003319709333226, 19398424.
38. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215. 10.1093/nar/16.3.1215, 334765, 3344216.
39. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 1995, 86:248-249.
40. R-development-core-team R: a language and environment for statistical computing. R Foundation for statistical Computing 2010, Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191. 10.3758/BF03193146, 17695343, R-development-core-team.
41. Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Control Clin Trials 1990, 11:116-128. 10.1016/0197-2456(90)90005-M, 2161310.
42. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C, Baralle FE. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 1990, 31(8):1371-1377.
43. Henkhaus RS, Dodani S, Manzardo AM, Butler MG. APOA1 gene polymorphisms in the South Asian immigrant population in the United States. Indian J Hum Genet 2011, 17(3):194-200. 10.4103/0971-6866.92103, 3276989, 22345992.
44. Smith JD, Brinton EA, Breslow JL. Polymorphism in the human apolipoprotein A-I gene promoter region: association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 1992, 89:1796-1800. 10.1172/JCI115783, 295877, 1601989.
45. Kamboh MI, Aston CE, Nestlerode CM, Mcallister AE, Hamman RF. Haplotype analysis of two ApoA1/MspI polymorphisms in relation to plasma levels of apoA-I and HDL-cholesterol. Atherosclerosis 1996, 127(2):255-262. 10.1016/S0021-9150(96)05966-7, 9125316.
46. Larson IA, Ordovas JM, Barnard JR, Hoffmann MM, Feussner G, Lamon-Fava S, Schaefer EJ. Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels. Clinical Genetics 2002, 61(3):176-184. 10.1034/j.1399-0004.2002.610302.x, 12000358.
47. Brown CM, Rea TJ, Hamon SC, Hixson JE, Boerwinkle E, Clark AG, Sing CF. The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability. J Mol Med (Berl) 2006, 84(7):561-572.
48. Boekholdt SM, Souverein OW, Tanck MW, Hovingh GK, Kuivenhoven JA, Peters RI, Jansen H, Schiffers PM, van der Wall EE, Doevendans PA, Reitsma PH, Zwinderman AH, Kastelein JJ, Jukema JW. Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin Genet 2006, 69(3):263-270. 10.1111/j.1399-0004.2006.00578.x, 16542392.
49. Haase CL, Tybjærg-Hansen A, Qayyum AA, Schou J, Nordestgaard BG, Frikke-Schmidt R. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocrinol Metab 2012, 97(2):E248-E256. 10.1210/jc.2011-1846, 22090275.
50. Al-Bustan SA, Alnaqeeb MA, Annice BG, Ibrahim G, Al-Rubaian J, Ahmed AH, Refai TM. Apolipoprotein E genotyping among the healthy Kuwaiti population. Hum Biol 2005, 77(4):487-498. 10.1353/hub.2005.0058, 16485778.
51. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, Jin Go M, Jin Kim Y, Lee JY, Park T, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466(7307):707-713. 10.1038/nature09270, 3039276, 20686565.
52. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, Goldstein BA, Stirrups K, König IR, Cazier JB, Johansson A, Hall AS, Lee JY, Willer CJ, Chambers JC, Esko T, Folkersen L, Goel A, Grundberg E, Havulinna AS, Ho WK, Hopewell JC, Eriksson N, Kleber ME, Kristiansson K, Lundmark P, Lyytikäinen LP , et al. CARDIoGRAMplusC4D Consortium Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013, 45(1):25-33. 3679547, 23202125, CARDIoGRAMplusC4D Consortium.